Tumeurs pédiatriques: L'apport de la proton thérapie - Partie 1/4

Please connect to access this resource and get a more personalized Campus experience

Connect

Executive summary

Après une introduction donnée par Claude Dupont, le Professeur émérite Jean-Louis Habrand du Centre de Lutte Contre Le Cancer François Baclesse a évoqué la protonthérapie comme moyen de prévenir les séquelles de la radiothérapie chez l'enfant. Mythe ou réalité ?

Vous pouvez trouver le reste du webinaire ici: Partie 2, Partie 3, Partie 4.

After an introduction given by Claude Dupont, Professor Jean-Louis Habrand at the François Baclesse Cancer Center discussed proton therapy as a means to prevent the sequelae of radiotherapy in children. Is it a myth or a reality?

You can find the rest of the webinar here: Part 2, Part 3, Part 4.

Top cancer treatments

Pediatric

Guest speakers

Jean-Louis

Habrand

Professor

Centre de lutte contre le cancer François Baclesse

Related contents

Webinar

18 October 2024

Empowering Cancer Care with Proton Therapy

Rakesh

Jalali

Srinivas

Chilukuri

Daniela

Alterio

Proton Therapy Publication

September 2024

Outcomes of proton therapy to infradiaphragmatic sites in pediatric patients with Hodgkin lymphoma.

Proton Therapy Publication

September 2024

Long-term outcomes following proton therapy for pediatric spinal low-grade glioma.

Proton Therapy Publication

June 2024

Late-onset lymphopenia during radiation is associated with an increased risk of tumor recurrence in newly diagnosed pediatric medulloblastoma.

Proton Therapy Publication

May 2024

Proton Therapy in Non-Rhabdomyosarcoma Soft Tissue Sarcomas of Children and Adolescents.

Proton Therapy Publication

May 2024

The cochlear dose and the age at radiotherapy predict severe hearing loss after passive scattering proton therapy and cisplatin in children with medulloblastoma.